Breweries & Distilleries · Founded 1983 · www.indiaglycols.com · BSE 500201 · NSE INDIAGLYCO · ISIN INE560A01023
No Notes Added Yet
Business
India Glycols Ltd. (IGL) is a leading manufacturer of Green Technology-based bulk chemicals, primarily utilizing renewable agro-based feedstock (molasses/ethanol route). Its core business revolves around the production of ethylene glycols (MEG, DEG, TEG), ethylene oxide (EO), and their derivatives. Beyond chemicals, IGL has diversified operations including the manufacturing and marketing of industrial gases (oxygen, nitrogen, argon), potable alcohol (Indian Made Foreign Liquor, country liquor, beer), specialty chemicals, and guar gum & derivatives. The company generates revenue by supplying these products to a wide range of industries such as textiles, pharmaceuticals, packaging, automotive, agriculture, and directly to consumers via its liquor brands.
Revenue Mix
IGL's primary revenue streams typically come from:
Chemicals & Solvents: This is generally the largest segment, encompassing glycols, specialty chemicals, performance chemicals, and industrial gases. It forms the bulk of their revenue.
Potable Alcohol (Spirits): This segment includes various alcoholic beverages like IMFL, country liquor, and beer, sold under their own brands or through contract manufacturing.
Guar Gum & Seed: This segment focuses on guar gum and its derivatives, used in food, oil & gas, and other industries.
Other: May include smaller contributions from bio-organic/bio-fertilizers and other diverse operations.
(Precise revenue contribution percentages vary by fiscal year and are not fabricated here, but Chemicals & Solvents typically account for the majority, followed by Potable Alcohol).
Industry
IGL operates in diverse industries. In Chemicals, it holds a unique position as a significant producer of bio-based glycols in India, differentiating itself from petrochemical-based manufacturers. The industry is competitive, with players ranging from large global chemical companies to specialized regional manufacturers. In Potable Alcohol, IGL competes in a highly regulated and fragmented Indian market against numerous national and regional brands. For Guar Gum, it operates within a commodity market where India is a dominant global supplier. IGL's "green" manufacturing process in chemicals provides a strategic positioning advantage amidst growing sustainability trends.
MOAT
Bio-based Manufacturing: IGL's primary competitive advantage lies in its unique "Green Technology" approach, manufacturing glycols from renewable agro-based feedstock (molasses/ethanol). This offers a degree of insulation from crude oil price volatility impacting petrochemical-based competitors and appeals to increasingly environmentally conscious customers.
Integrated Operations: The company benefits from a degree of integration from raw material sourcing (molasses/ethanol) to a diversified range of end-products, potentially offering cost efficiencies and better control over the supply chain.
Product Diversification: Operating across multiple distinct segments (chemicals, alcohol, guar gum) reduces dependence on a single market's cyclicality or specific regulatory changes.
Scale in Niche: As one of the significant players in bio-based glycols in India, it likely benefits from economies of scale within this particular manufacturing route.
Growth Drivers
Increasing Demand for Green Chemicals: Global and domestic demand for sustainable and eco-friendly products is a key driver for IGL's bio-based chemical offerings.
Capacity Expansion & Value Addition: Strategic investments in expanding existing capacities and developing higher-value specialty chemical derivatives can unlock new revenue streams.
Growth in Potable Alcohol Consumption: Rising disposable incomes, urbanization, and premiumization trends in India are expected to drive sustained growth in the alcoholic beverage market.
Government Focus on Bio-economy: Support for ethanol blending programs and bio-fuel initiatives can ensure favorable feedstock availability and pricing for IGL.
Export Opportunities: Growing international demand for sustainable chemical products can open up significant export markets.
Risks
Raw Material Price Volatility: Fluctuations in the prices of molasses/ethanol, driven by agricultural yields, government policies, and demand from the ethanol blending program, can impact profitability.
Regulatory Risks (Alcohol Segment): The alcohol industry in India is heavily regulated by state governments concerning taxes, licensing, and distribution, making it susceptible to adverse policy changes.
Intense Competition: IGL faces competition from large petrochemical players in chemicals and numerous domestic and international brands in the alcohol and guar gum segments.
Economic Slowdown: A general economic downturn could impact demand for both industrial chemicals and discretionary consumer goods like alcohol.
Environmental Regulations: Stringent environmental norms and compliance costs for chemical manufacturing pose ongoing operational risks.
Management & Ownership
India Glycols Ltd. is promoted by the S.K. Nevatia Group, with Mr. U.S. Bhartia serving as the Chairman and Managing Director. The promoter group typically holds a significant stake in the company, reflecting a long-term commitment. The management is generally perceived to have considerable experience in both the chemical and alcohol sectors, with a demonstrated focus on R&D and sustainable manufacturing practices.
Outlook
IGL's outlook is shaped by its unique position in bio-based chemicals and its diversified portfolio. The bull case envisions sustained growth driven by increasing global demand for green chemicals, successful expansion into high-value derivatives, and continued growth in the Indian alcohol market. Favorable government policies for ethanol and a stable raw material environment would further bolster profitability. The bear case highlights risks such as sharp increases in molasses/ethanol prices, adverse state-level regulatory changes in the alcohol sector, intense price-based competition across segments, or a broader economic slowdown affecting industrial demand. While the "green" advantage offers a strategic buffer, market dynamics and the regulatory landscape remain critical determinants of future performance.
| #(Fig in Cr.) | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2039 | 2283 | 2144 | 2424 | 2189 | 2503 | 2412 | 2551 | 2360 | 2988 |
| Other Income | 5 | 3 | 4 | 6 | 2 | 1 | 2 | 1 | 1 | 0 |
| Total Income | 2044 | 2285 | 2148 | 2430 | 2190 | 2505 | 2415 | 2552 | 2361 | 2989 |
| Total Expenditure | 1935 | 2157 | 2028 | 2300 | 2043 | 2353 | 2255 | 2376 | 2194 | 2819 |
| Operating Profit | 109 | 128 | 120 | 129 | 148 | 151 | 160 | 176 | 167 | 170 |
| Interest | 33 | 36 | 40 | 44 | 45 | 45 | 49 | 47 | 26 | 25 |
| Depreciation | 26 | 28 | 28 | 27 | 33 | 34 | 38 | 41 | 41 | 42 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
| Profit Before Tax | 51 | 65 | 53 | 58 | 70 | 72 | 72 | 87 | 99 | 102 |
| Provision for Tax | 13 | 15 | 14 | 15 | 18 | 17 | 19 | 23 | 26 | 26 |
| Profit After Tax | 37 | 50 | 39 | 43 | 53 | 55 | 54 | 64 | 74 | 76 |
| Adjustments | 5 | 11 | 11 | 13 | 11 | 19 | 12 | 3 | 13 | 21 |
| Profit After Adjustments | 42 | 60 | 50 | 57 | 64 | 73 | 65 | 68 | 87 | 97 |
| Adjusted Earnings Per Share | 6.8 | 9.8 | 8 | 9.2 | 10.3 | 11.8 | 10.5 | 10.1 | 13 | 14.4 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 2324 | 2500 | 3034 | 3357 | 2735 | 2317 | 2868 | 2651 | 3294 | 3768 | 4211 | 10311 |
| Other Income | 17 | 60 | 131 | 29 | 17 | 21 | 157 | 27 | 29 | 16 | 6 | 4 |
| Total Income | 2341 | 2560 | 3165 | 3385 | 2752 | 2338 | 3025 | 2678 | 3323 | 3784 | 4217 | 10317 |
| Total Expenditure | 2146 | 2310 | 2813 | 2945 | 2462 | 2052 | 2745 | 2355 | 2892 | 3257 | 3562 | 9644 |
| Operating Profit | 195 | 250 | 353 | 440 | 291 | 286 | 280 | 323 | 431 | 527 | 655 | 673 |
| Interest | 146 | 133 | 131 | 150 | 100 | 87 | 73 | 103 | 123 | 166 | 168 | 147 |
| Depreciation | 69 | 72 | 73 | 76 | 78 | 80 | 80 | 94 | 101 | 115 | 155 | 162 |
| Exceptional Income / Expenses | -61 | 0 | 0 | 0 | 0 | 0 | 221 | 28 | 0 | 0 | -1 | -1 |
| Profit Before Tax | -81 | 45 | 147 | 213 | 113 | 120 | 369 | 165 | 223 | 292 | 377 | 360 |
| Provision for Tax | -24 | 10 | 51 | 81 | 38 | 11 | 39 | 24 | 50 | 61 | 84 | 94 |
| Profit After Tax | -57 | 35 | 97 | 133 | 75 | 109 | 330 | 141 | 173 | 231 | 293 | 268 |
| Adjustments | 0 | 0 | 0 | 0 | 40 | 22 | 10 | -16 | 0 | 0 | 0 | 49 |
| Profit After Adjustments | -57 | 35 | 97 | 133 | 115 | 132 | 340 | 125 | 173 | 231 | 293 | 317 |
| Adjusted Earnings Per Share | -9.2 | 5.7 | 15.6 | 21.4 | 18.5 | 21.3 | 54.9 | 20.2 | 27.9 | 37.3 | 43.7 | 48 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 12% | 17% | 13% | 6% |
| Operating Profit CAGR | 24% | 27% | 18% | 13% |
| PAT CAGR | 27% | 28% | 22% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -68% | -2% | -6% | 16% |
| ROE Average | 11% | 10% | 12% | 9% |
| ROCE Average | 13% | 12% | 12% | 12% |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 718 | 752 | 845 | 963 | 1034 | 1169 | 1792 | 1901 | 2051 | 2256 | 2933 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | -19 | 0 | 0 | 0 | 0 |
| Borrowings | 195 | 65 | 172 | 396 | 407 | 508 | 540 | 551 | 725 | 1040 | 919 |
| Other Non-Current Liabilities | 870 | 773 | 739 | 701 | 661 | 675 | 570 | 541 | 466 | 559 | 657 |
| Total Current Liabilities | 1836 | 1902 | 1665 | 1725 | 1984 | 1733 | 1749 | 1865 | 2375 | 2321 | 2014 |
| Total Liabilities | 3620 | 3492 | 3421 | 3784 | 4086 | 4119 | 4631 | 4858 | 5617 | 6176 | 6523 |
| Fixed Assets | 2029 | 2110 | 2155 | 2165 | 2220 | 2185 | 2310 | 2709 | 3198 | 3827 | 4553 |
| Other Non-Current Assets | 311 | 248 | 185 | 232 | 269 | 223 | 712 | 502 | 474 | 533 | 472 |
| Total Current Assets | 1277 | 1132 | 1079 | 1385 | 1595 | 1328 | 1607 | 1646 | 1945 | 1816 | 1498 |
| Total Assets | 3620 | 3492 | 3421 | 3784 | 4086 | 4119 | 4631 | 4858 | 5617 | 6176 | 6523 |
| #(Fig in Cr.) | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 22 | 6 | 5 | 5 | 27 | 4 | 3 | 7 | 2 | 27 | 7 |
| Cash Flow from Operating Activities | 1231 | 302 | 502 | 147 | 343 | 137 | 116 | 326 | 439 | 362 | 769 |
| Cash Flow from Investing Activities | -78 | -40 | -103 | -128 | -151 | -148 | 76 | -330 | -503 | -736 | -767 |
| Cash Flow from Financing Activities | -1168 | -263 | -399 | 3 | -216 | 11 | -189 | -1 | 90 | 354 | 23 |
| Net Cash Inflow / Outflow | -15 | -1 | -0 | 22 | -23 | -0 | 4 | -5 | 25 | -20 | 25 |
| Closing Cash & Cash Equivalent | 6 | 5 | 5 | 27 | 4 | 3 | 7 | 2 | 27 | 7 | 32 |
| # | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | -9.17 | 5.66 | 15.59 | 21.42 | 18.52 | 21.25 | 54.88 | 20.2 | 27.94 | 37.29 | 43.68 |
| CEPS(Rs) | 2.05 | 17.29 | 27.39 | 33.73 | 24.61 | 30.57 | 66.19 | 37.95 | 44.21 | 55.9 | 66.86 |
| DPS(Rs) | 0 | 0.5 | 2 | 3 | 3 | 3 | 3.75 | 3.75 | 4 | 5 | 7.5 |
| Book NAV/Share(Rs) | 115.41 | 121.07 | 136.1 | 155.07 | 166.64 | 188.46 | 289.2 | 306.96 | 331.22 | 364.3 | 437.55 |
| Core EBITDA Margin(%) | 5.43 | 5.26 | 5.33 | 8.04 | 5.25 | 4.88 | 1.87 | 4.45 | 5.08 | 5.65 | 6.61 |
| EBIT Margin(%) | 1.96 | 4.93 | 6.69 | 7.09 | 4.08 | 3.81 | 6.7 | 4.04 | 4.38 | 5.07 | 5.55 |
| Pre Tax Margin(%) | -2.48 | 1.25 | 3.54 | 4.16 | 2.16 | 2.22 | 5.59 | 2.48 | 2.82 | 3.23 | 3.84 |
| PAT Margin (%) | -1.73 | 0.97 | 2.32 | 2.59 | 1.43 | 2.01 | 4.99 | 2.12 | 2.18 | 2.55 | 2.98 |
| Cash Profit Margin (%) | 0.39 | 2.97 | 4.08 | 4.08 | 2.92 | 3.49 | 6.21 | 3.54 | 3.46 | 3.83 | 4.56 |
| ROA(%) | -1.68 | 0.99 | 2.79 | 3.68 | 1.9 | 2.66 | 7.53 | 2.97 | 3.3 | 3.92 | 4.61 |
| ROE(%) | -11.26 | 4.79 | 12.12 | 14.71 | 7.51 | 9.93 | 22.29 | 7.64 | 8.76 | 10.72 | 11.28 |
| ROCE(%) | 2.86 | 9.39 | 15.8 | 19.95 | 10.72 | 9.62 | 17.28 | 9.21 | 10.89 | 12.33 | 12.73 |
| Receivable days | 44.6 | 38.12 | 31.75 | 23.38 | 31.16 | 31.29 | 21.02 | 22.78 | 18.76 | 15.12 | 13.3 |
| Inventory Days | 55.85 | 52.27 | 42.35 | 39.05 | 46.5 | 43.44 | 36.02 | 39.76 | 42.85 | 45.98 | 38.29 |
| Payable days | 100.8 | 131.47 | 132.59 | 146.21 | 157.26 | 177.51 | 130.1 | 193.25 | 187.15 | 185.71 | 138.23 |
| PER(x) | 0 | 14.14 | 14.51 | 6.53 | 5.75 | 9.81 | 9.22 | 15.19 | 13.54 | 14.88 | 19.44 |
| Price/Book(x) | 0.37 | 0.66 | 1.66 | 0.9 | 0.64 | 1.11 | 1.75 | 1 | 1.14 | 1.52 | 1.94 |
| Dividend Yield(%) | 0 | 0.62 | 0.88 | 2.15 | 2.82 | 1.44 | 0.74 | 1.22 | 1.06 | 0.9 | 0.88 |
| EV/Net Sales(x) | 0.63 | 0.62 | 0.72 | 0.52 | 0.57 | 1 | 1.42 | 1.09 | 1.07 | 1.37 | 1.71 |
| EV/Core EBITDA(x) | 7.5 | 6.24 | 6.17 | 3.98 | 5.32 | 8.09 | 14.52 | 8.93 | 8.18 | 9.8 | 11.02 |
| Net Sales Growth(%) | -9.9 | 7.54 | 21.39 | 10.62 | -18.51 | -15.3 | 23.79 | -7.58 | 24.26 | 14.4 | 11.76 |
| EBIT Growth(%) | 85.48 | 176.68 | 56.21 | 30.42 | -41.34 | -2.75 | 113.72 | -39.36 | 29.26 | 32.08 | 19.1 |
| PAT Growth(%) | 35.92 | 161.69 | 175.45 | 37.39 | -43.56 | 45.89 | 201.81 | -57.21 | 22.65 | 33.49 | 26.78 |
| EPS Growth(%) | 35.92 | 161.69 | 175.44 | 37.39 | -13.54 | 14.78 | 158.23 | -63.19 | 38.3 | 33.49 | 17.12 |
| Debt/Equity(x) | 1.73 | 1.46 | 0.99 | 1.04 | 0.95 | 0.96 | 0.58 | 0.58 | 0.64 | 0.8 | 0.54 |
| Current Ratio(x) | 0.7 | 0.59 | 0.65 | 0.8 | 0.8 | 0.77 | 0.92 | 0.88 | 0.82 | 0.78 | 0.74 |
| Quick Ratio(x) | 0.41 | 0.32 | 0.38 | 0.43 | 0.46 | 0.41 | 0.52 | 0.48 | 0.35 | 0.28 | 0.3 |
| Interest Cover(x) | 0.44 | 1.34 | 2.12 | 2.42 | 2.13 | 2.39 | 6.03 | 2.6 | 2.81 | 2.76 | 3.24 |
| Total Debt/Mcap(x) | 4.7 | 2.21 | 0.6 | 1.16 | 1.49 | 0.87 | 0.33 | 0.58 | 0.56 | 0.53 | 0.28 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 61.01 | 61.01 | 61.01 | 61.01 | 61.01 | 61.01 | 59.63 | 59.63 | 59.63 | 59.63 |
| FII | 1.75 | 2.9 | 2.44 | 2.25 | 3.44 | 2.62 | 2.42 | 2.27 | 2.24 | 2.76 |
| DII | 0.09 | 1.93 | 1.99 | 0.9 | 1.38 | 1.32 | 4.9 | 4.86 | 4.88 | 3.05 |
| Public | 37.15 | 34.15 | 34.55 | 35.84 | 34.17 | 35.04 | 33.05 | 33.24 | 33.24 | 34.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.89 | 1.89 | 1.89 | 1.89 | 1.89 | 3.78 | 4 | 4 | 4 | 4 |
| FII | 0.05 | 0.09 | 0.08 | 0.07 | 0.11 | 0.16 | 0.16 | 0.15 | 0.15 | 0.19 |
| DII | 0 | 0.06 | 0.06 | 0.03 | 0.04 | 0.08 | 0.33 | 0.33 | 0.33 | 0.2 |
| Public | 1.15 | 1.06 | 1.07 | 1.11 | 1.06 | 2.17 | 2.22 | 2.23 | 2.23 | 2.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 6.19 | 6.7 | 6.7 | 6.7 | 6.7 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +12% | +17% | +13% | +6% |
| Operating Profit CAGR | +24% | +27% | +18% | +13% |
| PAT CAGR | +27% | +28% | +22% | — |
| Share Price CAGR | -68% | -2% | -6% | +16% |
| ROE Average | +11% | +10% | +12% | +9% |
| ROCE Average | +13% | +12% | +12% | +12% |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 61.01 | 61.01 | 61.01 | 61.01 | 61.01 | 61.01 | 59.63 | 59.63 | 59.63 | 59.63 |
| FII | 1.75 | 2.9 | 2.44 | 2.25 | 3.44 | 2.62 | 2.42 | 2.27 | 2.24 | 2.76 |
| DII | 0.09 | 1.93 | 1.99 | 0.9 | 1.38 | 1.32 | 4.9 | 4.86 | 4.88 | 3.05 |
| Public | 37.15 | 34.15 | 34.55 | 35.84 | 34.17 | 35.04 | 33.05 | 33.24 | 33.24 | 34.56 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 1.89 | 1.89 | 1.89 | 1.89 | 1.89 | 3.78 | 4 | 4 | 4 | 4 |
| FII | 0.05 | 0.09 | 0.08 | 0.07 | 0.11 | 0.16 | 0.16 | 0.15 | 0.15 | 0.19 |
| DII | 0 | 0.06 | 0.06 | 0.03 | 0.04 | 0.08 | 0.33 | 0.33 | 0.33 | 0.2 |
| Public | 1.15 | 1.06 | 1.07 | 1.11 | 1.06 | 2.17 | 2.22 | 2.23 | 2.23 | 2.32 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3.1 | 3.1 | 3.1 | 3.1 | 3.1 | 6.19 | 6.7 | 6.7 | 6.7 | 6.7 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.